CHM 0.00% 0.9¢ chimeric therapeutics limited

court, page-19

  1. 529 Posts.
    Glyna

    If it is so easy to do the research show us how and what can be produced.

    You can go and get a MMX and CHM annual reports and statements which say very little. You have MMX word for it and CHM saying very little.

    There are no broker papers out there assessing case and MMX chances. Everyone is just relying on company positions.

    There are a few articles including a lot by Rebecca Urban but they dont really give any real analysis of the case.

    You talk about the 300k and what it compares to in terms of the overall cost. But that is comparing apples with oranges.

    CHM funds which I think you will find CHM is saying is higher than 300k was the most at risk funds employed in the entire history of the project.

    No $1.1 million cash component no deal.

    That is the core of what the judge will think about. I am sure he will recognise the work done later but it still comes back to without the CHM transactions none of the MMX story would have unfolded.

    What is the most at risk capital worth if CHM had particpated as a core equity partner.


 
watchlist Created with Sketch. Add CHM (ASX) to my watchlist
(20min delay)
Last
0.9¢
Change
0.000(0.00%)
Mkt cap ! $12.51M
Open High Low Value Volume
1.0¢ 1.0¢ 0.9¢ $9.539K 1.033M

Buyers (Bids)

No. Vol. Price($)
24 6042981 0.9¢
 

Sellers (Offers)

Price($) Vol. No.
1.0¢ 3771994 7
Last trade - 15.59pm 29/11/2024 (20 minute delay) ?
CHM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.